SUBSCRIBE
SUBSCRIBE

Preclinical

Drug Development
“New” Human Adenovirus May Not Make for Good Vaccines, After All AdHu26 Demonstrates Same Fault as Previously Studied Vaccine Vectors, The Wistar Institute Study
August 12, 2010
 · 
1 min read
Drug Development
Calgary Microchip ‘Talks’ to Brain Cells, University of Calgary Study
August 11, 2010
 · 
1 min read
Drug Development
Snail Venom Inspires Powerful Pain Reliever, University of Queensland Study
August 11, 2010
 · 
1 min read
Drug Development
Vitamin B3 as a Novel Approach to Treat Fungal Infections, University Of Montreal Study
August 11, 2010
 · 
1 min read
Drug Development
New Insights Into How Antibodies Are Made Suggests New Approach for Anti-Cancer Drug Targets, Babraham Institute Study
August 11, 2010
 · 
1 min read
Drug Development
Cancer’s ‘Addiction’ Spurs New Treatment Hopes, Yale University Study
August 10, 2010
 · 
1 min read
Drug Development
Scientists Regrow Section of Bone, Center of Innovation for Biomaterials in Orthopaedic Research Study
August 10, 2010
 · 
1 min read
Drug Development
Inhibiting Prostate Cancer Without Disturbing Regular Body Processes, McGill University Study
August 10, 2010
 · 
1 min read
Drug Development
Electrical Activity in Developing Brain Influences Choice of Neurotransmitter, University of California, San Diego (UCSD) Study
August 10, 2010
 · 
1 min read
Drug Development
Light Shed on Triglyceride Metabolism, University of California, Los Angeles (UCLA) Study
August 9, 2010
 · 
1 min read
Load More
PRESS RELEASES
Drug Development
Invenra to Present Preclinical Data on INV322, A Next Generation Tumor Treg Depleter
September 20, 2022
 · 
3 min read
Business
Atavistik Bio Announces Formation of Scientific Advisory Board
September 20, 2022
 · 
8 min read
Business
Octagon Therapeutics Enters Inflammation-Focused Research Alliance with Novo Nordisk
September 20, 2022
 · 
1 min read
Drug Development
NanOlogy Publishes Review Article of Preclinical and Clinical Research Supporting LSAM-DTX
September 20, 2022
 · 
3 min read
Drug Development
Bicycle Therapeutics Announces Publication of Article Highlighting Preclinical Data from BT8009 Program in Molecular Cancer Therapeutics
September 19, 2022
 · 
4 min read
Drug Development
Therapeutic Solutions International Spin-Off Company Campbell Neurosciences Announces Successful Preclinical Studies of CampbellCell for Treatment of Bipolar Disorder
September 19, 2022
 · 
3 min read
Drug Development
EXUMA Biotech to Present at the 2022 Cancer Immunology and Immunotherapy Conference and to Participate in the 7th Annual CAR-TCR Summit
September 16, 2022
 · 
3 min read
Drug Development
Confo Therapeutics Announces Poster Presentations on CFTX-1554 Preclinical Profiling and Mechanism of Action at the IASP 2022 World Congress on Pain
September 15, 2022
 · 
3 min read
Drug Development
J INTS BIO, poster presentation of further preclinical data of its Novel Oral 4th Generation EGFR-TKI ‘JIN-A02' at the 2022 European Society for Medical Oncology Congress in Paris, France (ESMO 2022)
September 15, 2022
 · 
2 min read
Drug Development
Astrocyte Pharmaceuticals Presents Update on AST-004 Clinical Program at 2022 Military Health System Research Symposium
September 14, 2022
 · 
3 min read
Drug Development
Gameto Announces New Funding and Preclinical Development Partnerships with Leading Global Fertility Clinics
September 14, 2022
 · 
4 min read
Drug Development
GentiBio To Present Preclinical Data Demonstrating Technical Progress to Engineer Regulatory T Cells for the Prevention and Treatment of Autoimmune Diseases
September 14, 2022
 · 
4 min read
Drug Development
Regen BioPharma, Inc. Begins Experiments Validating Its Proprietary CAR-T Cell Therapy
September 13, 2022
 · 
2 min read
Drug Development
Nuvectis Pharma Announces Positive Data for NXP800 in a Preclinical Model of ARID1a-Mutated Gastric Carcinoma
September 13, 2022
 · 
4 min read
Drug Development
First and only TIGIT/TGF-β dual-targeting antibody fusion protein of Akeso demonstrated promise in preclinical results published at ESMO
September 13, 2022
 · 
2 min read
Drug Development
Amylyx Pharmaceuticals Announces Publication of Preclinical Data Showing Potential Synergistic Effect of AMX0035 Compared to Individual Compounds
September 12, 2022
 · 
5 min read
Drug Development
Microbot Medical Commenced its First Step in the Anticipated Regulatory Process for its LIBERTY® Robotic System GLP Pre-Clinical Trial Commenced at a Leading Research Institute by Global Leaders in the Endovascular Space
September 12, 2022
 · 
2 min read
Drug Development
Enlivex Announces New Preclinical Data in Murine Mesothelioma Model Showing a Substantial Survival Benefit with Allocetra as Monotherapy and in Combination with Cisplatin at the ESMO Congress 2022
September 12, 2022
 · 
8 min read
Drug Development
SQZ Biotechnologies Presents Preclinical SQZ® TIL Data Supporting Potential Ability of mRNA-Driven IL-2 and IL-12 Expression to Eliminate Need for Toxic Preconditioning and Systemic IL-2 Administration for Certain T Cell Therapies
September 12, 2022
 · 
7 min read
Drug Development
Theratechnologies TH1902 Study Published in Pharmaceutics Demonstrates Inhibition of Human Sortilin (SORT1)-Positive Ovarian and Triple-Negative Breast Cancer Stem-Like Cells and Tumor Growth
September 12, 2022
 · 
7 min read
Load More